• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Nov 28 2022

Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older

This new plain language summary in Future Virology looks at the latest findings on the role of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

Read the full article here.

The original article on which this summary is based is called ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months’ and was originally published in the journal The New England Journal of Medicine. The original article can be read here.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Rachel Jenkins · Categorized: Infections, Vaccines · Tagged: COVID vaccine, COVID-19, lay summary, plain language summary, vaccine, vaccine development, vaccine efficacy, vaccine safety

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·